Location: Bend, OR
CIK: 0001440771 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 14, 2021
Total Value: $185M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | AMRYT PHARMA LTD | 2,523,728 | $35.16M | 19.0% | $13.51 | — | SPONSORED ADS | 03217L106 |
| — | ADAMAS PHARMACEUTICALS INC | 3,418,279 | $16.41M | 8.9% | $4.78 | — | COM | 00548A106 |
| — | CHIASMA INC | 4,940,273 | $15.46M | 8.4% | $3.30 | — | COM | 16706W102 |
| — | CATALYST BIOSCIENCES INC | 2,450,193 | $12.35M | 6.7% | $4.89 | — | COM NEW | 14888D208 |
| KALV | KALVISTA PHARMACEUTICALS INC | 422,310 | $10.85M | 5.9% | $26.28 | 0.0% | COM | 483497103 |
| OVID | OVID THERAPEUTICS INC | 2,483,059 | $9.982M | 5.4% | $3.32 | 0.0% | COM | 690469101 |
| — | CTI BIOPHARMA CORP | 3,293,419 | $9.584M | 5.2% | $2.44 | — | COM | 12648L601 |
| DMAC | DIAMEDICA THERAPEUTICS INC | 1,023,409 | $9.364M | 5.1% | $4.96 | +88.5% | COM NEW | 25253X207 |
| — | AFFIMED NV | 1,030,004 | $8.147M | 4.4% | $6.95 | — | COM | N01045108 |
| — | APOLLO ENDOSURGERY INC | 1,448,868 | $7.983M | 4.3% | $3.98 | — | COM | 03767D108 |
| XOMA | XOMA CORP | 163,266 | $6.663M | 3.6% | $20.10 | +92.5% | COM NEW | 98419J206 |
| — | YUMANITY THERAPEUTICS INC | 335,745 | $6.077M | 3.3% | $17.74 | — | COM | 98872L102 |
| — | IVERIC BIO INC | 875,180 | $5.409M | 2.9% | $1.92 | — | COM | 46583P102 |
| — | PLX PHARMA INC | 506,274 | $4.572M | 2.5% | $9.03 | — | COM | 72942A107 |
| — | CONFORMIS INC | 4,431,807 | $4.387M | 2.4% | $0.99 | — | COM | 20717E101 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 329,130 | $3.344M | 1.8% | $11.25 | 0.0% | COM NEW | 30233G209 |
| XGN | EXAGEN INC | 191,006 | $3.343M | 1.8% | $17.82 | 0.0% | COM | 30068X103 |
| — | AYTU BIOPHARMA INC | 362,910 | $2.758M | 1.5% | $5.98 | — | COM NEW | 054754874 |
| — | ANGION BIOMEDICA CORP | 134,984 | $2.439M | 1.3% | $18.07 | — | COM | 03476J107 |
| — | GAMIDA CELL LTD | 244,515 | $1.978M | 1.1% | $8.39 | — | SHS | M47364100 |
| CELC | CELCUITY INC | 109,081 | $1.564M | 0.8% | $14.22 | 0.0% | COM | 15102K100 |
| — | CONTRAFECT CORP | 269,101 | $1.292M | 0.7% | $4.80 | — | COM NEW | 212326300 |
| — | STRONGBRIDGE BIOPHARMA PLC | 445,701 | $1.23M | 0.7% | $2.10 | — | SHS USD | G85347105 |
| — | APTEVO THERAPEUTICS INC | 38,593 | $1.178M | 0.6% | $33.43 | — | COM NEW | 03835L207 |
| CRVS | CORVUS PHARMACEUTICALS INC | 316,279 | $974K | 0.5% | $3.61 | 0.0% | COM | 221015100 |
| — | APPLIED GENETIC TECHNOLOGIES | 179,511 | $910K | 0.5% | $5.07 | — | COM | 03820J100 |
| GLPG | GALAPAGOS NV | 10,000 | $771K | 0.4% | $77.10 | — | SPON ADR | 36315X101 |
| BWAY | BRAINSWAY LTD | 55,181 | $498K | 0.3% | $9.02 | — | SPONSORED ADS | 10501L106 |
| — | ONCOSEC MEDICAL INC | 94,783 | $452K | 0.2% | $4.77 | — | COM | 68234L306 |